Exhaled nitric oxide predictes steroid responsiveness

Nana Zhou,Cheng Chen,Xurui Shen,Jianan Huang,Xiuqin Zhang
DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2014.23.002
2014-01-01
Abstract:Objective To assess the value of FeNO to predicte steroid response of bronchial asthma (asthma) patients.Methods A total of 116 newly diagnosed asthmatic out-patients since April 2012 to March 2013 were enrolled to the investigation.The patients finished the FeNO measurement and Asthma Contral Test (ACT).Grouped by the FeNO level,FeNO≥50 ppb the high level group (46 cases),FeNO 25-50 ppb for the moderate group (44 cases),FeNO≤25 ppb for the mild group (26 cases).All patients inhaled corticosteroids combined with long-acting β2 agonists for 12 weeks,then measured FeNO and ACT again.Results Before treatment,the FeNO level negatively correlated with ACT score (r =-0.455,P < 0.000 1),after treatment it is not related (r =-0.171,P =0.066).The three groups FeNO decreased after treatment,high and moderate level group decreased significantly (t =16.83,t =14.53,P < 0.000 1),low level group did not (t =2.030,P =0.054).After treatment according to the ACT score we judged whether control,high level group the control rate was 81.4% vs moderate group 72.5% was not different (x2 =0.93,P >0.05),moderate level group vs mild group the contral rate 44.0% was significantly different (x2 =5.28,P <0.05).Conclusions FeNO can identify eosinophil inflammation in asthma and predict the efficacy of corticosteroid therapy.
What problem does this paper attempt to address?